{"": [85, 93, 0, 94, 881, 0], "Introduction": [882, 6015, 0], "SARS-CoV-2\u00a0S proteins can be displayed on two-component I53-50 nanoparticles": [6025, 9254, 0], "SARS-CoV-2 S-I53-50NPs enhance activation of SARS-CoV-2 S-protein-specific B cells in\u00a0vitro": [9255, 10713, 0], "SARS-CoV-2 S-I53-50NP vaccination induces robust NAb responses in small-animal models": [10714, 12786, 0], "SARS-CoV-2 S-I53-50NP vaccination induces potent humoral responses in cynomolgus macaques": [12787, 18267, 0], "SARS-CoV-2 S-I53-50NP vaccination protects cynomolgus macaques from high-dose SARS-CoV-2 challenge": [18268, 22868, 0], "Vaccinated cynomolgus macaques have reduced clinical manifestations": [22869, 23972, 0], "Results": [6016, 23972, 1], "Limitations of study": [29788, 30756, 0], "Discussion": [23973, 30756, 1], "KEY RESOURCES TABLE": [30771, 30796, 0], "Lead contact": [30820, 31008, 0], "Materials availability": [31009, 31132, 0], "Data and code availability": [31133, 31281, 0], "Resource availability": [30797, 31281, 1], "Cell lines": [31322, 32632, 0], "Cynomolgus macaques": [32633, 33615, 0], "Rabbits": [33616, 34011, 0], "Mice": [34012, 34362, 0], "Patient sera": [34363, 34705, 0], "Experimental model and subject details": [31282, 34705, 1], "Construct design": [34722, 35887, 0], "Protein expression and purification": [35888, 36806, 0], "I53-50B.4PT1 expression and purification": [36807, 37926, 0], "SARS-CoV-2 S-I53-50NP assembly": [37927, 38916, 0], "BN-PAGE analysis": [38917, 39116, 0], "Negative-stain EM": [39117, 39438, 0], "BLI assay": [39439, 39938, 0], "Glycopeptide analysis by liquid chromatography-mass spectrometry": [39939, 40812, 0], "Generation of B cells that stably express COVID-specific B cell receptors": [40813, 41981, 0], "B cell activation assay": [41982, 43013, 0], "Animals and study designs": [43014, 45579, 0], "Patient samples": [45580, 46113, 0], "ELISAs": [46114, 49449, 0], "Pseudovirus neutralization assay": [49450, 51147, 0], "Authentic virus neutralization assay": [51148, 52243, 0], "Protein coupling to Luminex beads": [52244, 53228, 0], "Luminex assays": [53229, 55083, 0], "SARS-CoV-2\u00a0S protein-specific CD4- and cTfh cell analysis using an activation induced marker (AIM) assay": [55084, 56640, 0], "SARS-CoV-2\u00a0S protein and RBD-specific B cell analysis": [56641, 57761, 0], "Viruses and cells": [57762, 58956, 0], "Virus quantification in cynomolgus macaque samples": [58957, 60084, 0], "Chest computed tomography and image analysis": [60085, 61338, 0], "ELISpot assays": [61339, 62147, 0], "Viral sequencing": [62148, 64224, 0], "Method details": [34706, 64224, 1], "Quantification and statistical analysis": [64225, 65224, 0], "STAR\u2605methods": [30757, 65224, 1]}